This site is intended for healthcare professionals only
LoginRegister
Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing PlantLupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant
Illegal Stockpiling Busted: Pregabalin, Alprazolam Medicines Seized in Ludhiana RaidExpired Drugs Repackaged? Crime Branch Exposes Illegal Pharma Racket Near Patna
Boehringer Ingelheim to Set Up AI-Driven Drug Discovery Centre in LondonUSFDA Grants Fast-Track Nod to Boehringer Ingelheim's Zongertinib for Rare Lung Cancer
SC Upholds Diploma Mandate for Bihar Pharmacist JobsSC Seeks Centre, DCGI Response on Micro Labs' Plea Against Anti-Diabetic FDC Ban
Alembic Pharma Sets Up Germany Arm to Expand European Market PresenceAlembic Bags USFDA Approval for USD 27 Million Lamotrigine ODT Market
USFDA Closes Inspection of Dr Reddys Srikakulam Facility with VAI ClassificationDr Reddy's Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: Report
Allahabad HC Denies Bail in Phensedyl Diversion Case, Accused Directed to SurrenderAllahabad HC Denies Bail in Phensedyl Diversion Case, Accused Directed to Surrender
Aurobindo Pharma Transfers Domestic Branded Business to Auropharm for Rs 143.21 CroreAurobindo's Eugia Arm Secures USFDA Nod for Transplant Drug Everolimus
Bayer Moves Court Against J&J Over Misleading Advertising on Cancer Drug ErleadaBayer Moves Court Against J&J Over Misleading Advertising on Cancer Drug Erleada
Alembic Pharma Wins USFDA Approval for Toenail Fungus Drug EfinaconazoleAlembic Pharma Wins USFDA Approval for Toenail Fungus Drug Efinaconazole
Biocon Gets USFDA Nod for gSaxenda, Enters US GLP-1 Weight Loss MarketBiocon Gets USFDA Nod for gSaxenda, Enters US GLP-1 Weight Loss Market
Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin AmericaShilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America
X